These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31481328)

  • 1. The End of the Beginning: The Journey to Molecular Therapies for Spinal Muscular Atrophy.
    Pacak CA; Kang PB
    Pediatr Neurol; 2020 Jan; 102():1-2. PubMed ID: 31481328
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-Nusinersen Hospitalization Costs of Children With Spinal Muscular Atrophy.
    Lee M; França UL; Graham RJ; McManus ML
    Pediatr Neurol; 2019 Mar; 92():3-5. PubMed ID: 30591237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gene-based therapies of spinal muscular atrophy: a piece of history of medicine].
    Braun S
    Med Sci (Paris); 2020 Feb; 36(2):141-146. PubMed ID: 32129750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More is needed to complement the available therapies of spinal muscular atrophy.
    Singh RN
    Future Med Chem; 2019 Nov; 11(22):2873-2876. PubMed ID: 31668092
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy for spinomuscular atrophy: a biomedical advance, a missed opportunity for more equitable drug pricing.
    Friedmann T
    Gene Ther; 2017 Sep; 24(9):503-505. PubMed ID: 28639617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal Muscular Atrophy in the Age of Gene Therapy.
    Williams L
    AACN Adv Crit Care; 2020 Mar; 31(1):86-91. PubMed ID: 32168519
    [No Abstract]   [Full Text] [Related]  

  • 7. Future avenues for therapy development for spinal muscular atrophy.
    Groen EJN
    Expert Opin Drug Discov; 2018 Oct; 13(10):899-902. PubMed ID: 30124076
    [No Abstract]   [Full Text] [Related]  

  • 8. Zolgensma - one-time gene therapy for spinal muscular atrophy.
    Med Lett Drugs Ther; 2019 Jul; 61(1577):113-114. PubMed ID: 31381549
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic therapy for spinal muscular atrophy.
    MacKenzie A
    Nat Biotechnol; 2010 Mar; 28(3):235-7. PubMed ID: 20212484
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances and challenges in developing a therapy for spinal muscular atrophy.
    Anderton RS; Mastaglia FL
    Expert Rev Neurother; 2015; 15(8):895-908. PubMed ID: 26200127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing therapies for spinal muscular atrophy.
    Wertz MH; Sahin M
    Ann N Y Acad Sci; 2016 Feb; 1366(1):5-19. PubMed ID: 26173388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-splicing, more than meets the eye: multifaceted therapeutics for spinal muscular atrophy.
    Butchbach ME
    Hum Gene Ther; 2011 Feb; 22(2):121-5. PubMed ID: 21288085
    [No Abstract]   [Full Text] [Related]  

  • 13. Spinal muscular atrophy: molecular pathophysiology.
    Gendron NH; MacKenzie AE
    Curr Opin Neurol; 1999 Apr; 12(2):137-42. PubMed ID: 10226744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian Perspective.
    Oskoui M; Gonorazky H; McMillan HJ; Dowling JJ; Amin R; Gagnon C; Selby K
    Can J Neurol Sci; 2022 May; 49(3):398-401. PubMed ID: 34082851
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy for spinal muscular atrophy: hope and caution.
    Goemans N
    Lancet Neurol; 2021 Apr; 20(4):251-252. PubMed ID: 33743228
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting splicing in spinal muscular atrophy.
    Burnett BG; Sumner CJ
    Ann Neurol; 2008 Jan; 63(1):3-6. PubMed ID: 18232015
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy for spinal muscular atrophy.
    Gowda VL; Jungbluth H; Wraige E
    Arch Dis Child Educ Pract Ed; 2023 Oct; 108(5):347-350. PubMed ID: 37423714
    [No Abstract]   [Full Text] [Related]  

  • 18. Maximising returns: combining newborn screening with gene therapy for spinal muscular atrophy.
    Gillingwater TH
    J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1252. PubMed ID: 34321342
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials.
    Zanetta C; Nizzardo M; Simone C; Monguzzi E; Bresolin N; Comi GP; Corti S
    Clin Ther; 2014 Jan; 36(1):128-40. PubMed ID: 24360800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our initial experiences with intravenous gene therapy for spinal muscular atrophy in children].
    Mikos B; Gergely A; Balázsfi R; Bányász E; Gyömörei B; Hantos M; Czelecz J; Jakus R; Kárász H; Zilahy M; Molnár E; Paraicz É; Csohány Á; Szénási F; Vendégh L; Fogarasi A; Velkey G
    Orv Hetil; 2020 Oct; 161(42):1806-1816. PubMed ID: 33070118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.